MCKENNA VELCHEK: Open Payments
NPI 1336766310 · FRANKLIN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,596 in 104 payments from 23 companies in 2025. Trend: 2023 $1,440 · 2024 $2,061 · 2025 $1,596
Food & beverage: $1,596
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 23 | $320 |
| ABBVIE INC. | 18 | $236 |
| Amgen Inc. | 15 | $143 |
| PFIZER INC. | 6 | $110 |
| GlaxoSmithKline, LLC. | 5 | $81 |
| Astellas Pharma US Inc | 3 | $77 |
| Xeris Pharmaceuticals, Inc. | 4 | $70 |
| Lilly USA, LLC | 4 | $70 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $62 |
| Corcept Therapeutics | 2 | $53 |
Products named: Ozempic, VRAYLAR, Veozah, TRELEGY ELLIPTA, CAPLYTA, EVENITY, Rybelsus, OTEZLA.
Industry payments across IN — which companies pay providers there.
